Skip to main content
Clinical Trials/NL-OMON55759
NL-OMON55759
Completed
Not Applicable

Optimal early recognition of persons at high risk of aneurysmal subarachnoid haemorrhage - ERASE

niversitair Medisch Centrum Utrecht0 sites500 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
500
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \- Age between 20 and 70 years
  • \- At least one first degree relative with an unruptured intracranial aneurysm
  • identified by MRA, CTA or conventional angiography

Exclusion Criteria

  • \- People who do not speak Dutch well enough to give informed consent
  • \- Any first degree relative with an aneurysmal subarachnoid hemorrhage
  • \- A history of an aneurysmal subarachnoid hemorrhage and/or unruptured
  • intracranial aneurysm
  • \- A history of polycystic kidney disease, Ehlers\-Danlos, or fibromuscular
  • \- Relative contraindication(s) for MRA, e.g. pregnancy, an internal metal
  • device such as a pacemaker, or claustrophobia
  • \- A serious condition that would interfere with the treatment of an UIA, e.g.
  • severe comorbidity or reduced life expectancy

Outcomes

Primary Outcomes

Not specified

Similar Trials